A critical review on the roles of natural products in shaping oral microbiota and preventing chronic diseases

doi:10.1007/s13659-026-00605-3

Abstract

Abstract: The oral microbiome plays a central role in maintaining both oral and systemic health, and disruptions in its balance can contribute to a wide range of diseases. This review brings together current evidence on how natural products modulate oral microbial communities, promote microbial equilibrium, and help prevent conditions such as dental caries, periodontitis, and chronic systemic disorders linked to oral dysbiosis. Recent studies highlight that phytochemicals particularly polyphenols, terpenoids, saponins, and alkaloids exert antimicrobial, anti-inflammatory, and antioxidant effects that influence bacterial adhesion, biofilm development, gene expression, and acid production. These compounds not only inhibit key oral pathogens but also support beneficial species, helping to sustain a stable and resilient microbiome. Evidence was gathered from PubMed, Scopus, ScienceDirect, and Google Scholar using relevant keywords and focusing on literature from 2015 to 2025. Insights into microbial diversity, environmental influences, host genetics, and advanced sequencing tools further strengthen understanding of oral microbial dynamics. While natural products show strong potential, challenges related to safety, bioavailability, regulatory clarity, and clinical translation remain to explore. This review outlines current progress and future directions needed to transform natural compounds into effective, evidence-based strategies for improving oral and systemic health through microbiome modulation.

Key words: Oral microbiota, Dysbiosis, Natural products, Chronic diseases, Microbiome modulation, Antimicrobial agents

摘要： The oral microbiome plays a central role in maintaining both oral and systemic health, and disruptions in its balance can contribute to a wide range of diseases. This review brings together current evidence on how natural products modulate oral microbial communities, promote microbial equilibrium, and help prevent conditions such as dental caries, periodontitis, and chronic systemic disorders linked to oral dysbiosis. Recent studies highlight that phytochemicals particularly polyphenols, terpenoids, saponins, and alkaloids exert antimicrobial, anti-inflammatory, and antioxidant effects that influence bacterial adhesion, biofilm development, gene expression, and acid production. These compounds not only inhibit key oral pathogens but also support beneficial species, helping to sustain a stable and resilient microbiome. Evidence was gathered from PubMed, Scopus, ScienceDirect, and Google Scholar using relevant keywords and focusing on literature from 2015 to 2025. Insights into microbial diversity, environmental influences, host genetics, and advanced sequencing tools further strengthen understanding of oral microbial dynamics. While natural products show strong potential, challenges related to safety, bioavailability, regulatory clarity, and clinical translation remain to explore. This review outlines current progress and future directions needed to transform natural compounds into effective, evidence-based strategies for improving oral and systemic health through microbiome modulation.

关键词: Oral microbiota, Dysbiosis, Natural products, Chronic diseases, Microbiome modulation, Antimicrobial agents

Yogesh Kumar, Baojun Xu. A critical review on the roles of natural products in shaping oral microbiota and preventing chronic diseases[J]. Natural Products and Bioprospecting, 2026, 16(3): 44-44.

Yogesh Kumar, Baojun Xu. A critical review on the roles of natural products in shaping oral microbiota and preventing chronic diseases[J]. 应用天然产物, 2026, 16(3): 44-44.

References

[1] Peng X, Cheng L, You Y, et al. Oral microbiota in human systematic diseases. Int J Oral Sci. 2022;14(1):14. https://doi.org/10.1038/s41368-022-00163-7.
[2] Rajasekaran JJ, Krishnamurthy HK, Bosco J, et al. Oral microbiome: a review of its impact on oral and systemic health. Microorganisms. 2024;12(9):1797. https://doi.org/10.3390/microorganisms12091797.
[3] Jia G, Zhi A, Lai PFH, et al. The oral microbiota—a mechanistic role for systemic diseases. Br Dent J. 2018;224(6):447-55. https://doi.org/10.1038/sj.bdj.2018.217.
[4] Graves DT, Corrêa JD, Silva TA. The oral microbiota is modified by systemic diseases. J Dent Res. 2019;98(2):148-56. https://doi.org/10.1177/0022034518805739.
[5] Hathaway‐Schrader JD, Novince CM. Maintaining homeostatic control of periodontal bone tissue. Periodontol 2000. 2021;86(1):157-87. https://doi.org/10.1111/prd.12368.
[6] Mohammed H, Varoni EM, Cochis A, et al. Oral dysbiosis in pancreatic cancer and liver cirrhosis: a review of the literature. Biomedicines. 2018;6(4):115. https://doi.org/10.3390/biomedicines6040115.
[7] Pisano M, Giordano F, Sangiovanni G, Capuano N, Acerra A, D’Ambrosio F. The interaction between the oral microbiome and systemic diseases: a narrative review. Microbiol Res. 2023;14(4):1862-78. https://doi.org/10.3390/microbiolres14040127.
[8] Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804-10. https://doi.org/10.1038/nature06244.
[9] Wilson MR, Zha L, Balskus EP. Natural product discovery from the human microbiome. J Biol Chem. 2017;292(21):8546-52. https://doi.org/10.1074/jbc.R116.762906.
[10] Pérez-Burillo S, Hinojosa-Nogueira D, Pastoriza S, Rufián-Henares JA. Plant extracts as natural modulators of gut microbiota community structure and functionality. Heliyon. 2020;6(11):e05474. https://doi.org/10.1016/j.heliyon.2020.e05474.
[11] Palmer Jr. Composition and development of oral bacterial communities. Periodontol 2000. 2014;64(1):20-39. https://doi.org/10.1111/j.1600-0757.2012.00453.x.
[12] Mark Welch JL, Ramírez-Puebla ST, Borisy GG. Oral microbiome geography: micron-scale habitat and niche. Cell Host Microbe. 2020;28(2):160-8. https://doi.org/10.1016/j.chom.2020.07.009.
[13] Könönen E. Development of oral bacterial flora in young children. Ann Med. 2000;32(2):107-12. https://doi.org/10.3109/07853890009011759.
[14] Deo P, Deshmukh R. Oral microbiome: unveiling the fundamentals. J Oral Maxillofac Pathol. 2019;23(1):122. https://doi.org/10.4103/jomfp.JOMFP_304_18.
[15] Willis JR, Gabaldón T. The human oral microbiome in health and disease: from sequences to ecosystems. Microorganisms. 2020;8(2):308. https://doi.org/10.3390/microorganisms8020308.
[16] Chaachouay N, Zidane L. Plant-derived natural products: a source for drug discovery and development. Drugs Drug Candidates. 2024;3(1):184-207. https://doi.org/10.3390/ddc3010011.
[17] Burcham ZM, Garneau NL, Comstock SS, et al. Patterns of oral microbiota diversity in adults and children: a crowdsourced population study. Sci Rep. 2020;10(1):2133. https://doi.org/10.1038/s41598-020-59016-0.
[18] Guo L, Zhou J, Xie F, et al. The profile of oral microbiome in Chinese elderly population associated with aging and systemic health status. BMC Oral Health. 2024;24(1):895. https://doi.org/10.1186/s12903-024-04676-x.
[19] Chen WP, Chang SH, Tang CY, Liou ML, Tsai SJJ, Lin YL. Composition analysis and feature selection of the oral microbiota associated with periodontal disease. Biomed Res Int. 2018;2018:1-14. https://doi.org/10.1155/2018/3130607.
[20] Chen X, Lin WY, Zhang FW, et al. Investigation of oral microbiome composition in elderly Chinese patients with hypertension: a cross-sectional study. J Oral Microbiol. 2025;17(1):2489603. https://doi.org/10.1080/20002297.2025.2489603.
[21] Bloch S, Hager-Mair FF, Andrukhov O, Schäffer C. Oral streptococci: modulators of health and disease. Front Cell Infect Microbiol. 2024. https://doi.org/10.3389/fcimb.2024.1357631.
[22] Zhu B, Macleod LC, Kitten T, Xu P. Streptococcus sanguinis biofilm formation & interaction with oral pathogens. Future Microbiol. 2018;13(8):915-32. https://doi.org/10.2217/fmb-2018-0043.
[23] Ren J, Sun P, Wang M, Zhou W, Liu Z. Insights into the role of Streptococcus oralis as an opportunistic pathogen in infectious diseases. Front Cell Infect Microbiol. 2024. https://doi.org/10.3389/fcimb.2024.1480961.
[24] Lemos JA, Palmer SR, Zeng L, et al. The biology of Streptococcus mutans. Microbiol Spectr. 2019. https://doi.org/10.1128/microbiolspec.gpp3-0051-2018.
[25] Ohara-Nemoto Y, Haraga H, Kimura S, Nemoto TK. Occurrence of staphylococci in the oral cavities of healthy adults and nasal-oral trafficking of the bacteria. J Med Microbiol. 2008;57(1):95-9. https://doi.org/10.1099/jmm.0.47561-0.
[26] Divakar DD, Aldeyab SS, Alfawaz SA, AlKheraif AA, Khan AA. High proportions of Staphylococcus epidermidis in dental caries harbor multiple classes of antibiotics resistance, significantly increase inflammatory interleukins in dental pulps. Microb Pathog. 2017;109:29-34. https://doi.org/10.1016/j.micpath.2017.05.017.
[27] Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30-44. https://doi.org/10.1038/nri3785.
[28] Chukkapalli SS, Rivera-Kweh MF, Velsko IM, et al. Chronic oral infection with major periodontal bacteria Tannerella forsythia modulates systemic atherosclerosis risk factors and inflammatory markers. Pathog Dis. 2015. https://doi.org/10.1093/femspd/ftv009.
[29] Dashper SG, Seers CA, Tan KH, Reynolds EC. Virulence factors of the oral spirochete Treponema denticola. J Dent Res. 2011;90(6):691-703. https://doi.org/10.1177/0022034510385242.
[30] Manome A, Abiko Y, Kawashima J, Washio J, Fukumoto S, Takahashi N. Acidogenic potential of oral Bifidobacterium and its high fluoride tolerance. Front Microbiol. 2019. https://doi.org/10.3389/fmicb.2019.01099.
[31] Najafi K, Ganbarov K, Gholizadeh P, et al. Oral cavity infection by Enterococcus faecalis: virulence factors and pathogenesis. Rev Med Microbiol. 2020;31(2):51-60. https://doi.org/10.1097/mrm.0000000000000168.
[32] Caufield PW, Schön CN, Saraithong P, Li Y, Argimón S. Oral Lactobacilli and dental caries: a model for niche adaptation in humans. J Dent Res. 2015;94(9_suppl):110S-118S. https://doi.org/10.1177/0022034515576052.
[33] Li Q, Zhou F, Su Z, Li Y, Li J. Corynebacterium matruchotii: a confirmed calcifying bacterium with a potentially important role in the supragingival plaque. Front Microbiol. 2022. https://doi.org/10.3389/fmicb.2022.940643.
[34] Könönen E, Wade WG. Actinomyces and related organisms in human infections. Clin Microbiol Rev. 2015;28(2):419-42. https://doi.org/10.1128/cmr.00100-14.
[35] Tsuzukibashi O, Uchibori S, Kobayashi T, et al. Isolation and identification methods of Rothia species in oral cavities. J Microbiol Methods. 2017;134:21-6. https://doi.org/10.1016/j.mimet.2017.01.005.
[36] Bottone EJ. Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev. 2010;23(2):382-98. https://doi.org/10.1128/cmr.00073-09.
[37] Perry A, Lambert P. Propionibacterium acnes: infection beyond the skin. Expert Rev Anti-Infect Ther. 2011;9(12):1149-56. https://doi.org/10.1586/eri.11.137.
[38] Henne K, Fuchs F, Kruth S, Horz HP, Conrads G. Shifts in Campylobacter species abundance may reflect general microbial community shifts in periodontitis progression. J Oral Microbiol. 2014;6(1):25874. https://doi.org/10.3402/jom.v6.25874.
[39] Rams TE, Feik D, Listgarten MA, Slots J. Peptostreptococcus micros in human periodontitis. Oral Microbiol Immunol. 1992;7(1):1-6. https://doi.org/10.1111/j.1399-302x.1992.tb00011.x.
[40] Han YW. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol. 2015;23:141-7. https://doi.org/10.1016/j.mib.2014.11.013.
[41] Könönen E, Fteita D, Gursoy UK, Gursoy M. Prevotella species as oral residents and infectious agents with potential impact on systemic conditions. J Oral Microbiol. 2022. https://doi.org/10.1080/20002297.2022.2079814.
[42] Lemberg C, Martinez De San Vicente K, Fróis-Martins R, et al. Candida albicans commensalism in the oral mucosa is favoured by limited virulence and metabolic adaptation. PLoS Pathog. 2022;18(4):e1010012. https://doi.org/10.1371/journal.ppat.1010012.
[43] Da Costa KRC, Ferreira JC, Komesu MC, Candido RC. Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity. Mycopathologia. 2009;167(2):73-9. https://doi.org/10.1007/s11046-008-9154-8.
[44] Zuza-Alves DL, Silva-Rocha WP, Chaves GM. An update on Candida tropicalis based on basic and clinical approaches. Front Microbiol. 2017. https://doi.org/10.3389/fmicb.2017.01927.
[45] DiNardo AR, Schmidt D, Mitchell A, Kaufman Y, Tweardy DJ. First description of oral ryptococcus neoformans causing osteomyelitis of the mandible, manubrium and third rib with associated soft tissue abscesses in an immunocompetent host. Clin Microbiol Case Rep. 2015;1(3):017.
[46] Peters BA, Wu J, Hayes RB, Ahn J. The oral fungal mycobiome: characteristics and relation to periodontitis in a pilot study. BMC Microbiol. 2017. https://doi.org/10.1186/s12866-017-1064-9.
[47] Monteiro‐da‐Silva F, Sampaio‐Maia B, Pereira MDL, Araujo R. Characterization of the oral fungal microbiota in smokers and non‐smokers. Eur J Oral Sci. 2013;121(2):132-5. https://doi.org/10.1111/eos.12030.
[48] Fadhil Ali Malaa S, Abd Ali Abd Aun Jwad B, Khalis Al-Masoudi H. Assessment of Entamoebagingivalis and trichomonastenax in patients with chronic disease and its correlation with some risk factors. Arch Razi Inst. 2021. https://doi.org/10.22092/ari.2021.356549.1868.
[49] Pilliol V, Mahmoud Abdelwadoud B, Aïcha H, et al. Methanobrevibacter oralis?: a comprehensive review. J Oral Microbiol. 2024. https://doi.org/10.1080/20002297.2024.2415734.
[50] Vianna ME, Conrads G, Gomes BPFA, Horz HP. T‐RFLP‐based mcrA gene analysis of methanogenic archaea in association with oral infections and evidence of a novel Methanobrevibacter phylotype. Oral Microbiol Immunol. 2009;24(5):417-22. https://doi.org/10.1111/j.1399-302X.2009.00539.x.
[51] Huynh HTT, Pignoly M, Nkamga VD, Drancourt M, Aboudharam G. The repertoire of Archaea cultivated from severe periodontitis. PLoS ONE. 2015;10(4):e0121565. https://doi.org/10.1371/journal.pone.0121565.
[52] Saravani S, Miri-Moghaddam E, Sanadgol N, Kadeh H, Nazeri MR. Human herpesvirus-6 and epstein-barr virus infections at different histopathological grades of oral squamous cell carcinomas. Int J Prev Med. 2014;5(10):1231-8.
[53] Banar M, Rokaya D, Azizian R, Khurshid Z, Banakar M. Oral bacteriophages: metagenomic clues to interpret microbiomes. PeerJ. 2024;12:e16947. https://doi.org/10.7717/peerj.16947.
[54] Maier T. Oral microbiome in health and disease: maintaining a healthy, balanced ecosystem and reversing dysbiosis. Microorganisms. 2023;11(6):1453. https://doi.org/10.3390/microorganisms11061453.
[55] Devaraja K, Aggarwal S. Dysbiosis of oral microbiome: a key player in oral carcinogenesis? A critical review. Biomedicines. 2025;13(2):448. https://doi.org/10.3390/biomedicines13020448.
[56] Li Y, He X, Luo G, Zhao J, Bai G, Xu D. Innovative strategies targeting oral microbial dysbiosis: unraveling mechanisms and advancing therapies for periodontitis. Front Cell Infect Microbiol. 2025. https://doi.org/10.3389/fcimb.2025.1556688.
[57] Hajishengallis G, Wang M, Bagby GJ, Nelson S. Importance of TLR2 in early innate immune response to acute pulmonary infection with Porphyromonas gingivalis in mice. J Immunol. 2008;181(6):4141-9. https://doi.org/10.4049/jimmunol.181.6.4141.
[58] Sonti R, Fleury C. Fusobacterium necrophorum presenting as isolated lung nodules. Respir Med Case Rep. 2015;15:80-2. https://doi.org/10.1016/j.rmcr.2015.05.011.
[59] Gomes‐Filho IS, Leitão De Oliveira TF, Seixas Da Cruz S, et al. Influence of periodontitis in the development of nosocomial pneumonia: a case control study. J Periodontol. 2014. https://doi.org/10.1902/jop.2013.130369.
[60] Leonov G, Salikhova D, Starodubova A, et al. Oral microbiome dysbiosis as a risk factor for stroke: a comprehensive review. Microorganisms. 2024;12(8):1732. https://doi.org/10.3390/microorganisms12081732.
[61] Sharma A, Novak EK, Sojar HT, Swank RT, Kuramitsu HK, Genco RJ. Porphyromonas gingivalisplatelet aggregation activity: outer membrane vesicles are potent activators of murine platelets. Oral Microbiol Immunol. 2000;15(6):393-6. https://doi.org/10.1034/j.1399-302x.2000.150610.x.
[62] Pussinen PJ, Jousilahti P, Alfthan G, Palosuo T, Asikainen S, Salomaa V. Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;23(7):1250-4. https://doi.org/10.1161/01.atv.0000072969.71452.87.
[63] Velsko IM, Chukkapalli SS, Rivera MF, et al. Active invasion of oral and aortic tissues by Porphyromonas gingivalis in mice causally links periodontitis and atherosclerosis. PLoS ONE. 2014;9(5):e97811. https://doi.org/10.1371/journal.pone.0097811.
[64] Slocum C, Coats SR, Hua N, Gunn JS, ed, et al. Distinct lipid A moieties contribute to pathogen-induced site-specific vascular inflammation. PLoS Pathog. 2014;10(7):e1004215. https://doi.org/10.1371/journal.ppat.1004215.
[65] Chukkapalli SS, Rivera MF, Velsko IM, Blanke SR, ed, et al. Invasion of oral and aortic tissues by oral spirochete Treponema denticola in ApoE ^-/- mice causally links periodontal disease and atherosclerosis. Infect Immun. 2014;82(5):1959-67. https://doi.org/10.1128/iai.01511-14.
[66] Figuero E, Sánchez‐Beltrán M, Cuesta‐Frechoso S, et al. Detection of periodontal bacteria in atheromatous plaque by nested polymerase chain reaction. J Periodontol. 2011;82(10):1469-77. https://doi.org/10.1902/jop.2011.100719.
[67] Preshaw PM, Alba AL, Herrera D, et al. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2012;55(1):21-31. https://doi.org/10.1007/s00125-011-2342-y.
[68] Popławska-Kita A, Siewko K, Szpak P, et al. Association between type 1 diabetes and periodontal health. Adv Med Sci. 2014;59(1):126-31. https://doi.org/10.1016/j.advms.2014.01.002.
[69] Yang Y, Sun X, Yang Y, Qie Y. Insight of the interrelationship and association mechanism between periodontitis and diabetes mellitus. Regenerative Therapy. 2024;26:1159-67. https://doi.org/10.1016/j.reth.2024.11.001.
[70] Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor‐α in a 2‐way relationship. J Periodontol. 2003;74(1):97-102. https://doi.org/10.1902/jop.2003.74.1.97.
[71] Li Y, Qian F, Cheng X, Kaspar JR, ed, et al. Dysbiosis of oral microbiota and metabolite profiles associated with type 2 diabetes mellitus. Microbiol Spectr. 2023. https://doi.org/10.1128/spectrum.03796-22.
[72] Tao K, Yuan Y, Xie Q, Dong Z. Relationship between human oral microbiome dysbiosis and neuropsychiatric diseases: an updated overview. Behav Brain Res. 2024;471:115111. https://doi.org/10.1016/j.bbr.2024.115111.
[73] Sparks Stein P, Steffen MJ, Smith C, et al. Serum antibodies to periodontal pathogens are a risk factor for Alzheimer’s disease. Alzheimers Dement. 2012;8(3):196-203. https://doi.org/10.1016/j.jalz.2011.04.006.
[74] Gaur S, Agnihotri R. Alzheimer’s disease and chronic periodontitis: is there an association? Geriatr Gerontol Int. 2015;15(4):391-404. https://doi.org/10.1111/ggi.12425.
[75] Abbayya K, Chidambar Y, Naduwinmani S, Puthanakar N. Association between periodontitis and alzheimer's disease. North Am J Med Sci. 2015;7(6):241. https://doi.org/10.4103/1947-2714.159325.
[76] Kamer AR, Craig RG, Pirraglia E, et al. TNF-α and antibodies to periodontal bacteria discriminate between Alzheimer’s disease patients and normal subjects. J Neuroimmunol. 2009;216(1-2):92-7. https://doi.org/10.1016/j.jneuroim.2009.08.013.
[77] Cestari JAF, Fabri GMC, Kalil J, et al. Oral infections and cytokine levels in patients with Alzheimer’s disease and mild cognitive impairment compared with controls. J Alzheimers Dis. 2016;52(4):1479-85. https://doi.org/10.3233/jad-160212.
[78] Poole S, Singhrao SK, Chukkapalli S, et al. Active invasion of Porphyromonas gingivalis and infection-induced complement activation in ApoE-/- mice brains. J Alzheimers Dis. 2014;43(1):67-80. https://doi.org/10.3233/jad-140315.
[79] Poole S, Singhrao SK, Kesavalu L, Curtis MA, Crean S. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue. J Alzheimers Dis. 2013;36(4):665-77. https://doi.org/10.3233/jad-121918.
[80] Hammond CJ, Hallock LR, Howanski RJ, Appelt DM, Little CS, Balin BJ. Immunohistological detection of Chlamydia pneumoniae in the Alzheimer’s disease brain. BMC Neurosci. 2010. https://doi.org/10.1186/1471-2202-11-121.
[81] Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in Alzheimer’s disease, role of cytokines. Sci World J. 2012;2012:1-15. https://doi.org/10.1100/2012/756357.
[82] McGeer P. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging. 2001;22(6):799-809. https://doi.org/10.1016/s0197-4580(01)00289-5.
[83] Akiyama H. Inflammation and Alzheimer’s disease. Neurobiol Aging. 2000;21(3):383-421. https://doi.org/10.1016/s0197-4580(00)00124-x.
[84] Nannan M, Xiaoping L, Ying J. Periodontal disease in pregnancy and adverse pregnancy outcomes: progress in related mechanisms and management strategies. Front Med. 2022. https://doi.org/10.3389/fmed.2022.963956.
[85] Han YW, Wang X. Mobile microbiome: oral bacteria in extra-oral infections and inflammation. J Dent Res. 2013;92(6):485-91. https://doi.org/10.1177/0022034513487559.
[86] Han YW, Fardini Y, Chen C, et al. Term stillbirth caused by oral Fusobacterium nucleatum. Obstet Gynecol. 2010;115(2):442-5. https://doi.org/10.1097/aog.0b013e3181cb9955.
[87] Gauthier S, Tétu A, Himaya E, et al. The origin of Fusobacterium nucleatum involved in intra-amniotic infection and preterm birth. J Matern Fetal Neonatal Med. 2011;24(11):1329-32. https://doi.org/10.3109/14767058.2010.550977.
[88] Katz J, Chegini N, Shiverick KT, Lamont RJ. Localization of P. gingivalis in preterm delivery placenta. J Dent Res. 2009;88(6):575-8. https://doi.org/10.1177/0022034509338032.
[89] Schenkein HA, Bradley JL, Purkall DB. Anticardiolipin in Porphyromonas gingivalis antisera causes fetal loss in mice. J Dent Res. 2013;92(9):814-8. https://doi.org/10.1177/0022034513497959.
[90] Abrahams VM, Mor G. Toll-like receptors and their role in the trophoblast. Placenta. 2005;26(7):540-7. https://doi.org/10.1016/j.placenta.2004.08.010.
[91] Chaparro A, Blanlot C, Ramírez V, et al. Porphyromonas gingivalis,Treponema denticola and toll‐like receptor 2 are associated with hypertensive disorders in placental tissue: a case-control study. J Periodontal Res. 2013;48(6):802-9. https://doi.org/10.1111/jre.12074.
[92] Kaur M, Geisinger ML, Geurs NC, et al. Effect of intensive oral hygiene regimen during pregnancy on periodontal health, cytokine levels, and pregnancy outcomes: a pilot study. J Periodontol. 2014;85(12):1684-92. https://doi.org/10.1902/jop.2014.140248.
[93] Vamos CA, Thompson EL, Avendano M, Daley EM, Quinonez RB, Boggess K. Oral health promotion interventions during pregnancy: a systematic review. Community Dent Oral Epidemiol. 2015;43(5):385-96. https://doi.org/10.1111/cdoe.12167.
[94] Fall-Dickson JM, Pavletic SZ, Mays JW, Schubert MM. Oral complications of chronic graft-versus-host disease. JNCI Monogr. 2019. https://doi.org/10.1093/jncimonographs/lgz007.
[95] Santos PSDS. Oral graft vs host disease: an immune system disorder in hematopoietic cell transplantation. World J Stomatol. 2015;4(2):96. https://doi.org/10.5321/wjs.v4.i2.96.
[96] Johnson LB, Oh U, Rothen M, et al. A review of oral chronic graft-versus-host disease: considerations for dental hygiene practice. J Dent Hyg JDH. 2022;96(2):6-17.
[97] Dean D, Sroussi H. Oral chronic graft-versus-host disease. Front Oral Health. 2022;3. https://doi.org/10.3389/froh.2022.903154
[98] Kambara Y, Fujiwara H, Yamamoto A, et al. Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host disease. Blood. 2025;145(8):881-96. https://doi.org/10.1182/blood.2024024540.
[99] Rashidi A, Pidala J, Hamilton BK, et al. Oral and gut microbiome alterations in oral chronic GVHD disease: results from close assessment and testing for chronic GVHD (CATCH study). Clin Cancer Res. 2024;30(18):4240-50. https://doi.org/10.1158/1078-0432.ccr-24-0875.
[100] Stein-Thoeringer C, Peled JU, Lazrak A, et al. Domination of the gut microbiota with Enterococcus species early after allogeneic bone marrow transplantation is an important contributor to the development of acute graft-versus-host disease (GHVD) in mouse and man. Biol Blood Marrow Transplant. 2018;24(3):S40-1. https://doi.org/10.1016/j.bbmt.2017.12.594.
[101] Li S, Su B, He QS, Wu H, Zhang T. Alterations in the oral microbiome in HIV infection: causes, effects and potential interventions. Chin Med J (Engl). 2021;134(23):2788-98. https://doi.org/10.1097/cm9.0000000000001825.
[102] Dang AT, Cotton S, Sankaran-Walters S, et al. Evidence of an increased pathogenic footprint in the lingual microbiome of untreated HIV infected patients. BMC Microbiol. 2012. https://doi.org/10.1186/1471-2180-12-153.
[103] Coker MO, Mongodin EF, El-Kamary SS, et al. Immune status, and not HIV infection or exposure, drives the development of the oral microbiota. Sci Rep. 2020. https://doi.org/10.1038/s41598-020-67487-4.
[104] Veerapandian R, Paudyal A, Schneider SM, Lee STM, Vediyappan G. A mouse model of immunosuppression facilitates oral Candida albicans biofilms, bacterial dysbiosis and dissemination of infection. Front Cell Infect Microbiol. 2025. https://doi.org/10.3389/fcimb.2024.1467896.
[105] Zhang S, Kong C, Yang Y, et al. Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer. Theranostics. 2020;10(25):11595-606. https://doi.org/10.7150/thno.49515.
[106] Talapko J, Erić S, Meštrović T, et al. The impact of oral microbiome dysbiosis on the aetiology, pathogenesis, and development of oral cancer. Cancers. 2024;16(17):2997. https://doi.org/10.3390/cancers16172997.
[107] Zhi J, Liang Y, Zhao W, et al. Oral microbiome-derived biomarkers for non-invasive diagnosis of head and neck squamous cell carcinoma. NPJ Biofilms Microbiomes. 2025. https://doi.org/10.1038/s41522-025-00708-8.
[108] Elghannam MT, Hassanien MH, Ameen YA, et al. Oral microbiome dysbiosis and gastrointestinal diseases: a narrative review. Egypt Liver J. 2024;14(1). https://doi.org/10.1186/s43066-024-00340-9
[109] Gallimidi AB, Fischman S, Revach B, et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6(26):22613-23. https://doi.org/10.18632/oncotarget.4209.
[110] Inaba H, Sugita H, Kuboniwa M, et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation: promotion of oral cancer invasion by P. gingivalis. Cell Microbiol. 2014;16(1):131-45. https://doi.org/10.1111/cmi.12211.
[111] Wen BW, Tsai CS, Lin CL, et al. Cancer risk among gingivitis and periodontitis patients: a nationwide cohort study. QJM. 2014;107(4):283-90. https://doi.org/10.1093/qjmed/hct248.
[112] Yao QW, Zhou DS, Peng HJ, Ji P, Liu DS. Association of periodontal disease with oral cancer: a meta-analysis. Tumor Biol. 2014;35(7):7073-7. https://doi.org/10.1007/s13277-014-1951-8.
[113] Michaud DS, Fu Z, Shi J, Chung M. Periodontal disease, tooth loss, and cancer risk. Epidemiol Rev. 2017;39(1):49-58. https://doi.org/10.1093/epirev/mxx006.
[114] Xiao L, Zhang Q, Peng Y, Wang D, Liu Y. The effect of periodontal bacteria infection on incidence and prognosis of cancer: a systematic review and meta-analysis. Medicine (Baltimore). 2020;99(15):e19698. https://doi.org/10.1097/md.0000000000019698.
[115] Arzani V, Soleimani M, Fritsch T, Jacob UM, Calabrese V, Arzani A. Plant polyphenols, terpenes, and terpenoids in oral health. Open Med. 2025;20(1):20251183. https://doi.org/10.1515/med-2025-1183.
[116] Zandavar H, Afshari Babazad M. Secondary Metabolites: Alkaloids and flavonoids in medicinal plants. In: Ivanišová E, editor. Herbs and spices—new advances. IntechOpen; 2023. https://doi.org/10.5772/intechopen.108030
[117] Spatafora G, Li Y, He X, Cowan A, Tanner ACR. The evolving microbiome of dental caries. Microorganisms. 2024;12(1):121. https://doi.org/10.3390/microorganisms12010121.
[118] Othman L, Sleiman A, Abdel-Massih RM. Antimicrobial activity of polyphenols and alkaloids in Middle Eastern plants. Front Microbiol. 2019;10:911. https://doi.org/10.3389/fmicb.2019.00911.
[119] Scott MB, Styring AK, McCullagh JSO. Polyphenols: bioavailability, microbiome interactions and cellular effects on health in humans and animals. Pathogens. 2022;11(7):770. https://doi.org/10.3390/pathogens11070770.
[120] Gloria-Garza MA, Reyna-Martínez GR, Jiménez-Salas Z, et al. Medicinal plants against dental caries: research and application of their antibacterial properties. Plants. 2025;14(9):1390. https://doi.org/10.3390/plants14091390.
[121] Kong C, Zhang H, Li L, Liu Z. Effects of green tea extract epigallocatechin-3-gallate (EGCG) on oral disease-associated microbes: a review. J Oral Microbiol. 2022. https://doi.org/10.1080/20002297.2022.2131117.
[122] Li Y, Cheng L, Li M. Effects of green tea extract epigallocatechin-3-gallate on oral diseases: a narrative review. Pathogens. 2024;13(8):634. https://doi.org/10.3390/pathogens13080634.
[123] Nijampatnam B, Zhang H, Cai X, Michalek SM, Wu H, Velu SE. Inhibition of Streptococcus mutans biofilms by the natural stilbene piceatannol through the inhibition of glucosyltransferases. ACS Omega. 2018;3(7):8378-85. https://doi.org/10.1021/acsomega.8b00367.
[124] Stevens CS, Rosado H, Harvey RJ, Taylor PW. Epicatechin gallate, a naturally occurring polyphenol, alters the course of infection with β-lactam-resistant Staphylococcus aureus in the zebrafish embryo. Front Microbiol. 2015. https://doi.org/10.3389/fmicb.2015.01043.
[125] Koo H, Duarte S, Murata RM, et al. Influence of cranberry proanthocyanidins on formation of biofilms by Streptococcus mutans on saliva-coated apatitic surface and on dental caries development in vivo. Caries Res. 2010;44(2):116-26. https://doi.org/10.1159/000296306.
[126] Lee JH, Regmi SC, Kim JA, et al. Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect Immun. 2011;79(12):4819-27. https://doi.org/10.1128/iai.05580-11.
[127] Makarewicz M, Drożdż I, Tarko T, Duda-Chodak A. The interactions between polyphenols and microorganisms, especially gut microbiota. Antioxidants. 2021;10(2):188. https://doi.org/10.3390/antiox10020188.
[128] Siddiqui T, Khan MU, Sharma V, Gupta K. Terpenoids in essential oils: chemistry, classification, and potential impact on human health and industry. Phytomedicine Plus. 2024;4(2):100549. https://doi.org/10.1016/j.phyplu.2024.100549.
[129] Riaz M, Khalid R, Afzal M, et al. Phytobioactive compounds as therapeutic agents for human diseases: a review. Food Sci Nutr. 2023;11(6):2500-29. https://doi.org/10.1002/fsn3.3308.
[130] Ulanowska M, Olas B. Biological properties and prospects for the application of eugenol—a review. Int J Mol Sci. 2021;22(7):3671. https://doi.org/10.3390/ijms22073671.
[131] Moo CL, Yang SK, Osman MA, et al. Antibacterial activity and mode of action of β-caryophyllene on Bacillus cereus. Pol J Microbiol. 2020;69(1):49-54. https://doi.org/10.33073/pjm-2020-007.
[132] Kubo I, Muroi H, Himejima M. Antibacterial activity of totarol and its potentiation. J Nat Prod. 1992;55(10):1436-40. https://doi.org/10.1021/np50088a008.
[133] Lei Q, Chen J, Yuan Y, et al. The inhibitory effects of ginsenosides on periodontitis pathogenic bacteria. Front Microbiol. 2025. https://doi.org/10.3389/fmicb.2025.1573969.
[134] Chen Y, Gao Y, Li Y, Yin J. Anti-biofilm activity of Assamsaponin A, Theasaponin E1, and Theasaponin E2 against Candida albicans. Int J Mol Sci. 2024;25(7):3599. https://doi.org/10.3390/ijms25073599.
[135] Veerapandian R, Vediyappan G. Gymnemic acids inhibit adhesive nanofibrillar mediated Streptococcus gordonii-Candida albicans mono-species and dual-species biofilms. Front Microbiol. 2019. https://doi.org/10.3389/fmicb.2019.02328.
[136] Hu J, Takahashi N, Yamada T. Coptidis Rhizoma inhibits growth and proteases of oral bacteria. Oral Dis. 2000;6(5):297-302. https://doi.org/10.1111/j.1601-0825.2000.tb00142.x.
[137] Kouidhi B, Al Qurashi YMA, Chaieb K. Drug resistance of bacterial dental biofilm and the potential use of natural compounds as alternative for prevention and treatment. Microb Pathog. 2015;80:39-49. https://doi.org/10.1016/j.micpath.2015.02.007.
[138] Chang AW, Dowd SE, Brackee G, Fralick JA, Vediyappan G. Inhibition of Staphylococcus aureus biofilm formation by gurmarin, a plant-derived cyclic peptide. Front Cell Infect Microbiol. 2022. https://doi.org/10.3389/fcimb.2022.1017545.
[139] Topa SH, Palombo EA, Kingshott P, Blackall LL. Activity of cinnamaldehyde on quorum sensing and biofilm susceptibility to antibiotics in Pseudomonas aeruginosa. Microorganisms. 2020;8(3):455. https://doi.org/10.3390/microorganisms8030455.
[140] Zeng Y, Nikitkova A, Abdelsalam H, Li J, Xiao J. Activity of quercetin and kaemferol against Streptococcus mutans biofilm. Arch Oral Biol. 2019;98:9-16. https://doi.org/10.1016/j.archoralbio.2018.11.005.
[141] Rudin L, Kneubühler J, Dubey BN, Ahmad S, Bornstein MM, Shyp V. Inhibitory effect of plant flavonoid cyanidin on oral microbial biofilm. Microbiol Spectr. 2025;13(6):e02848-24. https://doi.org/10.1128/spectrum.02848-24.
[142] Chinsembu KC. Plants and other natural products used in the management of oral infections and improvement of oral health. Acta Trop. 2016;154:6-18. https://doi.org/10.1016/j.actatropica.2015.10.019.
[143] Ibrahim SM, Khalel AM. Revolutionizing dental therapy: a comprehensive review on the innovative use of natural extracts in tooth care and treatment. Curr Tradit Med. 2025;12:e22150838410159. https://doi.org/10.2174/0122150838410159250909103512.
[144] Anwar MA, Sayed GA, Hal DM, et al. Herbal remedies for oral and dental health: a comprehensive review of their multifaceted mechanisms including antimicrobial, anti-inflammatory, and antioxidant pathways. Inflammopharmacology. 2025;33(3):1085-160. https://doi.org/10.1007/s10787-024-01631-8.
[145] Boloor VA, Hosadurga R, Rao A, Jenifer H, Pratap S. Unconventional dentistry in India-an insight into the traditional methods. J Tradit Complement Med. 2014;4(3):153-8. https://doi.org/10.4103/2225-4110.130951.
[146] Deshmukh N, Ikhar A, Paul P. Traditional practices of oral health care among tribals of India: a scoping review. MRIMS J Health Sci. 2024;12(1):1-7. https://doi.org/10.4103/mjhs.mjhs_52_23.
[147] Mathpati MM, Yalsangi M, Narayan R. Where do traditional healers fit in the dentist-centred oral health system? An ethnography inquiry among the indigenous communities in Gudalur, South India. SSM Health Syst. 2025;4:100079. https://doi.org/10.1016/j.ssmhs.2025.100079